Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 5 institutions in 3 countries.
Andrew J LesseyEndocrine Signalling Group, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK.
Samantha M MirczukEndocrine Signalling Group, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK.
Annisa N ChandEndocrine Signalling Group, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK.
Deborah M KurraschDepartment of Medical Genetics, University of Calgary, Calgary, AB T2N 4N2, Canada.
Márta KorbonitsCentre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.ORCID 0000-0002-4101-9432
Stijn J M NiessenClinical Sciences & Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire AL9 7TA, UK.
Craig A McArdleDepartment of Translational Science, Bristol Medical School, University of Bristol, Whitson Street, Bristol BS1 3NY, UK.
Imelda M McGonnellComparative Biomedical Sciences, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK.ORCID 0000-0002-9800-7248
Robert C FowkesEndocrine Signalling Group, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK.ORCID 0000-0002-2222-2056
University of London · GBQueen Mary University of London · GBRoyal Veterinary College · GBUniversity of Bristol · GBUniversity of Calgary · CA
Funding
Biotechnology and Biological Sciences Research Council BB/L002795/1Wellcome Trust WT093257MA
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Pharmacological and Genetic Disruption of C-Type Natriuretic Peptide ( · full record | OpenQuestion